Must-Know Finance Concepts for Life Sciences Valuations

This whitepaper gives an introduction to the key concepts and most common methodologies used to evaluate life sciences assets.

In this whitepaper you'll learn:


  • The most common various valuation methodologies

  • Methodologies used by pharma and venture capitalists 

  • Three fundamental concepts in valuation
  • download THE
    WHITEPAPER

    WHITEPAPER AUTHOR:

    Company team

    Jeff Karan

    Co-Founder and Managing Partner of WaveEdge Capital

    Jeff brings over 30 years of investment
    banking and corporate advisory
    experience to WaveEdge Capital.  In
    addition to his extensive knowledge
    of capital raising and merger &
    acquisitions, Jeff has advised clients on corporate strategy, business valuation,
    and a wide range of strategic partnership structures. Learn More

    Company team

    John Selig

    Co-Founder and Managing Partner of WaveEdge Capital

    John advises life sciences companieson M&A, licensing and financial strategy. Heteaches the valuation and finance module at BIO’s Executive Management course for BD professionals and at Stanford Medical School’s Entrepreneurship program. Learn More


    Sponsored by: